Anti-glutamic Acid Decarboxylase Antibody-associated Cerebellar Ataxia: A Case Report

Miray Atacan Yaşgüçlükal, Cansu Tunç, Muhammet Duran Bayar, Birgül Baştan, Sefer Günaydın, Belgin Petek Balcı, Özlem Çokar

DOI: 10.4274/tnd.2020.93457

Issue: 2021, Volume 27 - Issue 1
0 324

Family History of Headache and Epistaxis Associated with Ischemic Stroke

Eu Jene Choi, Dong Goo Lee, Do-Hyung Kim, Sang Hyun Jang

DOI: 10.4274/tnd.2020.48902

Issue: 2020, Volume 26 - Issue 4
0 327

Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke

Beuy Joob, Viroj Wowanitkit

DOI: 10.4274/tnd.2020.99897

Issue: 2020, Volume 26 - Issue 4
0 289

Balance and Gait Impairment in Persons with Multiple Sclerosis with the Absence of Clinical Disability

Hatice Ayan, Özge Ertekin, Turhan Kahraman, Serkan Özakbaş

DOI: 10.4274/tnd.2020.36036

Issue: 2020, Volume 26 - Issue 3
0 340

A Multifaceted Evaluation of National Off-label Neurology Applications

Şükran Yurtoğulları, Hanife Rahmanlar, Ali Alkan, Banu Bayar, Hakkı Gürsöz, Nurten Uzun Adatepe

DOI: 10.4274/tnd.2020.37791

Issue: 2020, Volume 26 - Issue 3
0 342

The Role of Neurologist in the Assessment and Treatment of Depression

Emre Kumral, Fatma Ece Bayam

DOI: 10.4274/tnd.2019.44341

Issue: 2020, Volume 26 - Issue 1
0 312

Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis

Yeliz Salcı, Ecem Karanfil, Ender Ayvat, Ayla Fil Balkan, Jale Karakaya, Songül Aksoy, Kadriye Armutlu, Aslı Kurne, Rana Karabudak

DOI: 10.4274/tnd.2019.34392

Issue: 2020, Volume 26 - Issue 1
0 295

Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Canan Duman İlki, Tuncay Gündüz, Murat Kürtüncü, Zuhal Yapıcı, Serra Sencer, Mefküre Eraksoy

DOI: 10.4274/tnd.2019.77010

Issue: 2020, Volume 26 - Issue 1
0 327

The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke

Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu

DOI: 10.4274/tnd.2019.09735

Issue: 2019, Volume 25 - Issue 4
0 318

Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study

Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler

DOI: 10.4274/tnd.2019.33341

Issue: 2019, Volume 25 - Issue 4
0 313

Screening Inherited Metabolic Disorder in Children with Intellectual Disability and Epilepsy

Pembe Soylu Üstkoyuncu, Ahmet Sami Güven, Hatice Gamze Poyrazoğlu, Songül Gökay, Fatih Kardaş, Mustafa Kendirci, İkbal Gökçek, Yasemin Altuner Torun

DOI: 10.4274/tnd.2019.82608

Issue: 2019, Volume 25 - Issue 3
0 323

The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis

Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal

DOI: 10.4274/tnd.2019.04207

Issue: 2019, Volume 25 - Issue 3
0 313

What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance

Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk

DOI: 10.4274/tnd.2019.93206

Issue: 2019, Volume 25 - Issue 3
0 349

Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?

Bahar Say, Ufuk Ergün

DOI: 10.4274/tnd.2019.87513

Issue: 2019, Volume 25 - Issue 3
0 389

Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes

İpek Güngör Doğan

DOI: 10.4274/tnd.2019.97720

Issue: 2019, Volume 25 - Issue 3
0 288

The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results

Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale

DOI: 10.4274/tnd.2019.75725

Issue: 2019, Volume 25 - Issue 2
0 283

Stenting of Carotid Artery Using the Brachial Artery Approach

Gökhan Özdemir, Gözde Ongun

DOI: 10.4274/tnd.2019.36604

Issue: 2019, Volume 25 - Issue 2
0 254

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis

Halil Önder

DOI: 10.4274/tnd.2019.05925

Issue: 2019, Volume 25 - Issue 2
0 247

Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort

Ayşe İlksen Çolpak, Duygu Gülmez Sevim, Aslı Tuncer, Sevda Diker, Rana Karabudak, Sibel Kadayıfçılar, Tülay Kansu

DOI: 10.4274/tnd.2018.33230

Issue: 2019, Volume 25 - Issue 1
0 285

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Miraç Ayşen Ünsal

DOI: 10.4274/tnd.2019.00187

Issue: 2019, Volume 25 - Issue 1
0 295